Ruponen Marika, Urtti Arto
School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
School of Pharmacy, University of Eastern Finland, Kuopio, Finland; Centre for Drug Research, Division of Pharmaceutical Biosciences, University of Helsinki, Helsinki, Finland.
Eur J Pharm Biopharm. 2015 Oct;96:442-6. doi: 10.1016/j.ejpb.2015.02.032. Epub 2015 Mar 12.
Mucus layer covers the ocular surface, and soluble mucins are also present in the tear fluid. After topical ocular drug administration, the drugs and formulations may interact with mucus layer that may act as a barrier in ocular drug delivery. In this mini-review, we illustrate the mucin composition of the ocular surface and discuss the influence of mucus layer on ocular drug absorption. Based on the current knowledge the role of mucus barrier in drug delivery is still undefined. Furthermore, interactions with mucus may prolong the retention of drug formulations on the ocular surface. Mucus may decrease or increase ocular bioavailability depending on the magnitude of its role as barrier or retention site, respectively. Mechanistic studies are needed to clarify the role of mucin in ocular drug delivery.
黏液层覆盖眼表,泪液中也存在可溶性黏蛋白。局部眼部给药后,药物和制剂可能会与黏液层相互作用,而黏液层可能在眼部药物递送中起到屏障作用。在这篇小型综述中,我们阐述了眼表的黏蛋白组成,并讨论了黏液层对眼部药物吸收的影响。基于目前的知识,黏液屏障在药物递送中的作用仍不明确。此外,与黏液的相互作用可能会延长药物制剂在眼表的滞留时间。黏液可能会分别根据其作为屏障或滞留部位的作用程度降低或增加眼部生物利用度。需要进行机制研究以阐明黏蛋白在眼部药物递送中的作用。